These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4164180)

  • 1. [Use of "Eviprostat" on hypertrophy of the prostate].
    Gotoh K; Kimura T; Isogai K; Nishi M; Ohtani F
    Hinyokika Kiyo; 1966 Jun; 12(6):583-92. PubMed ID: 4164180
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical use of eviprostat for hypertrophy of prostate].
    Inada T; Sakatoku J; Ebisuta K; Kitayama T
    Hinyokika Kiyo; 1966 Apr; 12(4):403-9. PubMed ID: 4163784
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of the phytotherapeutic agent Eviprostat on 17beta-estradiol-induced nonbacterial inflammation in the rat prostate.
    Oka M; Ueda M; Oyama T; Kyotani J; Tanaka M
    Prostate; 2009 Sep; 69(13):1404-10. PubMed ID: 19489033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of prostatic hypertrophy with eviprostat].
    Kubo Y; Inoue S; Ono T; Yasui A
    Hinyokika Kiyo; 1966 Dec; 12(12):1463-7. PubMed ID: 4167083
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of Eviprostat for treatment of prostatic hypertrophy].
    Ookita K; Shiraga T; Matsumura Y
    Hinyokika Kiyo; 1966 May; 12(5):511-7. PubMed ID: 4164092
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of a phytotherapeutic agent, Eviprostat®, on prostatic and urinary cytokines/chemokines in a rat model of nonbacterial prostatitis.
    Sugimoto M; Oka M; Tsunemori H; Yamashita M; Kakehi Y
    Prostate; 2011 Mar; 71(4):438-44. PubMed ID: 21254154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vitaprost forte efficacy in patients with prostatic adenoma].
    Tkachuk VN; Tkachuk IN
    Urologiia; 2008; (4):34-7. PubMed ID: 19058362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical effects of chlormadinone acetate (Prostal) on patients with prostatic hypertrophy--with reference to estimation of size and weight of prostate by means of transrectal ultrasonotomography].
    Yoshida H; Haraguchi C; Ogawa Y; Kawai N; Ohyama M; Higaki Y; Saitoh T; Imamura K
    Hinyokika Kiyo; 1983 Nov; 29(11):1419-26. PubMed ID: 6203377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Conservative therapy of prostatic adenoma as well as prostatitis with beta-sitosterol prostate capsules].
    Karcher G
    Med Welt; 1982 Dec; 33(48):1763-6. PubMed ID: 6185822
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of prostamol-Uno on oxidative and local immune status in patients with benign prostatic hyperplasia and chronic prostatitis].
    Seregin SP; Bratchikov OI; Konoplia AI; Shestakov SG; Dolzhenkov SD; Novikov AV; Shatokhin MN; Kotov AV
    Urologiia; 2002; (4):14-6. PubMed ID: 12357892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of spastic complications in prostate and bladder diseases with Spasmo-Urgenin].
    Hartung F; Massier J
    Med Welt; 1968 May; 19():1262-3. PubMed ID: 4181968
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of prostatitis with doxycycline].
    Oosterlinck W; Wijndaele JJ
    Nouv Presse Med; 1980 Jan; 9(21 Suppl):128-30. PubMed ID: 6153464
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapeutic efficacy of sitosterin prostate capsules in prostatic adenoma and prostatitis. Results of a field study].
    Dörner G; Fritsche C
    ZFA (Stuttgart); 1982 Jan; 58(3):167-9. PubMed ID: 6176081
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of cernilton in the therapy of prostatic adenoma and chronic prostatitis].
    Shaplygin LV; Sivakov AA
    Urologiia; 2007; (3):35-7, 39. PubMed ID: 17722618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Assessment of clinical usefulness of Eviprostat for benign prostatic hyperplasia--comparison of Eviprostat tablet with a formulation containing two-times more active ingredients].
    Tamaki M; Nakashima M; Nishiyama R; Ikeda H; Hiura M; Kanaoka T; Nakano T; Hayashi T; Ogawa O
    Hinyokika Kiyo; 2008 Jun; 54(6):435-45. PubMed ID: 18634442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The weak site of the stronger sex. Phytotherapy often helps the prostate patient].
    MMW Fortschr Med; 1999 Oct; 141(41):70. PubMed ID: 10904649
    [No Abstract]   [Full Text] [Related]  

  • 17. Inflammation and glandular proliferation in hyperplastic prostates: association with prostate specific antigen value.
    Banu NA; Azim FA; Kamal M; Rumi MA; Barua AR; Khan KH
    Bangladesh Med Res Counc Bull; 2001 Dec; 27(3):79-83. PubMed ID: 12197626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-blind, randomized controlled study of the clinical and urodynamic effects of an alpha-blocker (naftopidil) and phytotherapy (eviprostat) in the treatment of benign prostatic hyperplasia.
    Yamanishi T; Yasuda K; Kamai T; Tsujii T; Sakakibara R; Uchiyama T; Yoshida K
    Int J Urol; 2004 Jul; 11(7):501-9. PubMed ID: 15242359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Stimulating substitution therapy with tradon in the treatment of prostate diseases during the cure at a medicinal spring for kidney and bladder disorders].
    Feiber W
    Landarzt; 1964 Nov; 40(32):1399-400. PubMed ID: 4157558
    [No Abstract]   [Full Text] [Related]  

  • 20. [Efficacy of vitaprost forte in patients with prostatic adenoma].
    Miller AM; Iaroshenko VP; Soroka PV; Stakhnev EIu
    Urologiia; 2008; (5):50, 52-4. PubMed ID: 19069497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.